Persistence of Signs and Symptoms in Treated Patients with C3G: Evidence from Real-World Data
Clare Proudfoot, Katharina Pannagl, Briana Ndife, Serge Smeets, Kathleen Murphy, Jonathan de Courcy, Susanna Libby, Richard Lafayette
Real-World Time to Diagnosis in C3G
Clare Proudfoot, Katharina Pannagl, Briana Ndife, Serge Smeets, Kathleen Murphy, Jonathan de Courcy, Susanna Libby, Richard Lafayette
C3 Glomerulopathy Current Treatment Options and Real-World Management - Results from a Multi-Country Study
Clare Proudfoot, Katharina Pannagl, Briana Ndife, Serge Smeets, Kathleen Murphy, Jonathan de Courcy, Susanna Libby, Richard Lafayette
Signs and Symptoms at Diagnosis in Patients with C3 Glomerulopathy - Results from a Real-World Multi-Country Study
Clare Proudfoot, Katharina Pannagl, Briana Ndife, Serge Smeets, Kathleen Murphy, Jonathan de Courcy, Susanna Libby, Richard Lafayette
Patient characteristics and renal outcomes of C3G and IC-MPGN in the UK: a retrospective analysis of 287 patients in the UK National Registry of Rare Kidney Diseases (RaDaR)
Lewis Downward, Katie Wong, Clare Proudfoot, Nicholas Webb, Edwin K. Wong, Daniel P.Gale
Further insights into iptacopan mode of action in IgA nephropathy through protein profiling
Andrea Grioni, Mykola Lysetskiy, Anna Kostikova, Anastasiia Zub, Oksana Ikkert, Oleksandr Karmash, Yaryna Shalai, Anna Schubart, Claire Harris, Matthias Meier, Marie-Anne Valentin, Dmitrij Kollins
Treatment of IgA Nephropathy in Chinese Patients: Evidence from Real-World Data
Wang Weiming, Li Runqin, Li Ping, Gao Fei, Serge Smeets, Aneesh Thomas George, Jonathan de Courcy
Demographic, clinical characteristics and treatment outcomes of C3 glomerulopathy in China: A nationwide retrospective cohort study
Nie Sheng, Zhou Shiyu, Gao Qi, Li Ping, Gao Fei, Zhang Shaosen
Characteristics of patients with complement 3 glomerulopathy (C3G) in a US multi-center assessment
Briana Ndife, Carolina Aldworth, Kathleen P Murphy, Jennifer Nguyen, Irina Pivneva, Marie Louise Edwards, Annika Anderson, James Signorovitch, Pietro Canetta
CKD progression in patients with complement 3 glomerulopathy (C3G) in a US multi-center assessment
Briana Ndife, Carolina Aldworth, Kathleen P Murphy, Jennifer Nguyen, Irina Pivneva, Marie Louise Edwards, Annika Anderson, James Signorovitch, Pietro Canetta
Clinical burden of IgA nephropathy (IgAN) in the US: a retrospective electronic medical record (EMR) and claims analysis
Briana Ndife, Carolina Aldworth, Jennifer Nguyen, Stephen Olson, Elizabeth Nagelhout, Marley Boyd, Deval Gor
Atypical hemolytic uremic syndrome (aHUS) clinical characteristics and outcomes during index hospitalization in the era of C5 inhibitor therapy (C5i)
Stephen Olson, Briana Ndife, Jennifer Nguyen, Elizabeth Nagelhout, Andrea Barthel, Yingjie Ding
Atypical hemolytic uremic syndrome (aHUS) clinical characteristics associated with renal replacement therapy (RRT) initiation during index hospitalization and RRT requirement after discharge
Stephen Olson, Briana Ndife, Jennifer Nguyen, Elizabeth Nagelhout, Colette Ndiba-Markey, Swastina Shrestha
Atypical hemolytic uremic syndrome (aHUS) clinical characteristics and treatment patterns associated with mortality during index hospitalization
Stephen Olson, Briana Ndife, Jennifer Nguyen, Elizabeth Nagelhout, Andrea Barthel, Deval Gor
Identifying opportunities to improve early referral for hematuria with concomitant proteinuria in a large health system
Alexander R Chang, Thomas Jones, Yirui Hu, Jamie Green, Lauren Gummo, Jennifer Nguyen, Briana Ndife, Carolina Aldworth